RESUMEN
OBJECTIVE: Testicular cancer is a relatively rare neoplasia, with an incidence of about 1,5% among male malignancies, usually in the third and fourth decade of life. Although several histological variants are known, with some histotypes affecting older patients (e.g., spermatocytic seminoma), there is a clear predominance (90-95%) of germ cell tumors among young adults patients1. Testicular Germ Cell Tumor (TGCT), undoubtedly the seminoma histological variant more than non-seminoma one, is definitely a highly curable disease, with a distinctive sensitivity to cisplatin-based therapy (and for seminomas to radiotherapy) and an outstanding cure rate of nearly 80% even for patients with advanced disease. So far, clinical and pathohistological features supported our efforts to choose the best treatment option for patients suffering from this malignancy, but we don't clearly enough know molecular and pathological features underlying different clinical behaviors, mostly in early-stage disease: by improving this knowledge, we should better "shape" therapeutic or surveillance programs for each patient, also in order to avoid unnecessary, if not harmful, treatments.
Asunto(s)
Neoplasias Testiculares/patología , Antineoplásicos/uso terapéutico , Cisplatino/uso terapéutico , Humanos , Masculino , Estadificación de Neoplasias , Neoplasias de Células Germinales y Embrionarias/tratamiento farmacológico , Neoplasias de Células Germinales y Embrionarias/metabolismo , Neoplasias de Células Germinales y Embrionarias/patología , Pronóstico , Seminoma/metabolismo , Seminoma/patología , Seminoma/radioterapia , Neoplasias Testiculares/tratamiento farmacológico , Neoplasias Testiculares/metabolismoRESUMEN
OBJECTIVE: Congenital hypothyroidism (CH) with delayed thyroid-stimulating hormone (TSH) elevation is a common form of thyroid dysfunction among premature infants. Routine newborn screening (NBS) may miss infants with CH with delayed TSH elevation. The objective of the study is to determine the prevalence of CH with delayed TSH elevation in premature infants and to identify associated risk factors. STUDY DESIGN: Retrospective analysis of serum thyroid function screening (TFS) at day of life 30 in premature infants <30 weeks gestation, admitted to University of Iowa Neonatal Intensive Care Unit between 1 July 2012 to 30 June 2015. Serum free thyroxine and TSH levels were obtained in premature infants <30 weeks gestation on day of life 30. Follow-up testing and pediatric endocrinology consultation were done according to the institutional protocol. RESULT: In total, 286 infants were included. All infants underwent routine NBS and 280 patients underwent TFS. Twenty-six patients (9.1%) were diagnosed with thyroid dysfunction. NBS identified only three patients. CH with delayed TSH elevation was diagnosed in 20 patients (6.9%) and was significantly associated with multiple gestation, lower birth weight, higher gestational age and lower 5 min APGAR score. CONCLUSION: Thyroid dysfunction is common among premature infants born before 30 weeks gestation. The majority of cases with thyroid dysfunction had CH with delayed TSH elevation, which was not detected by NBS. We recommend measurement of serum TSH and free T4 levels on day of life 30 in premature infants born at <30 weeks gestation to identify patients with CH with delayed TSH elevation.
Asunto(s)
Hipotiroidismo Congénito/sangre , Hipotiroidismo Congénito/diagnóstico , Recien Nacido Prematuro/sangre , Tirotropina/sangre , Tiroxina/sangre , Peso al Nacer , Femenino , Edad Gestacional , Humanos , Lactante , Recién Nacido , Unidades de Cuidado Intensivo Neonatal , Iowa , Modelos Logísticos , Masculino , Tamizaje Neonatal/métodos , Estudios RetrospectivosRESUMEN
BACKGROUND: Data from the general population show higher prevalence of different anxiety disorders in women as compared with men. We analysed gender differences in a naturalistic sample of outpatients with anxiety disorders in a mental healthcare setting. METHOD: Routine outcome monitoring data were collected from 1333 patients (age: 18-65; 63.3% women) fulfilling Diagnostic and Statistical Manual of Mental Disorders IV criteria of current anxiety disorder according to the Mini-International Neuropsychiatric Interview between 2004 through 2006. Data included Comprehensive Psychopathological Rating Scale, Brief Symptom Inventory (BSI), Short Form Health Survey (SF-36), Mood and Anxiety Symptom Questionnaire (MASQ). Chi-squared test and t-test were used to compare women with men for variables with parametric distributions, and Mann-Whitney test for non-parametric distribution. Adjustments for potential confounders (age, level of education, ethnicity and comorbidites) were made by logistic regression models (for discrete variables) or analysis of covariance. RESULTS: The female-to-male ratio (i.e., 844 women, 489 men) for any anxiety disorder was 1.73 : 1 (95% confidence interval [CI]: 1.63-1.83), with the strongest skewness for post-traumatic stress disorder (2.80 : 1) and the smallest one for social phobia (1.18 : 1). Compared with men, women reported more severe self-rating scores on the BSI (on average, the scores were 12.3% higher on 3 of 9 subscales: somatisation, interpersonal sensitivity and anxiety), SF-36 (self-reported generic health status was lower on 5 of 8 subscales: physical functioning, social functioning, physical problems, vitality and bodily pain) and MASQ (on average, the scores were 6.6% higher on 4 of 5 subscales: anxious arousal, general distress, general distress depression, general distress anxiety). On the contrary, no gender difference was found in the severity of anxiety symptoms measured by the Brief Anxiety Scale. Women were more likely to suffer from comorbid depression and bulimia nervosa, and less likely from substance abuse. CONCLUSIONS: In a treatment-seeking population the prevalence rate of anxiety disorders was 1.7 times higher in female compared with men. Female outpatients were more severely affected on self-rated but not on observer-rated scales.
Asunto(s)
Trastornos de Ansiedad/epidemiología , Pacientes Ambulatorios , Adolescente , Adulto , Anciano , Trastornos de Ansiedad/complicaciones , Trastornos de Ansiedad/diagnóstico , Manual Diagnóstico y Estadístico de los Trastornos Mentales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Trastornos por Estrés Postraumático , Adulto JovenRESUMEN
Short-term mechanical ventilation with high tidal volume (HVT) causes mild to moderate lung injury and impairs active Na+ transport and lung liquid clearance in rats. Dopamine (DA) enhances active Na+ transport in normal rat lungs by increasing Na+-K+-ATPase activity in the alveolar epithelium. We examined whether DA would increase alveolar fluid reabsorption in rats ventilated with HVT for 40 min compared with those ventilated with low tidal volume (LVT) and with nonventilated rats. Similar to previous reports, HVT ventilation decreased alveolar fluid reabsorption by ~50% (P < 0.001). DA increased alveolar fluid reabsorption in nonventilated control rats (by ~60%), LVT ventilated rats (by approximately 55%), and HVT ventilated rats (by ~200%). In parallel studies, DA increased Na+-K+-ATPase activity in cultured rat alveolar epithelial type II cells (ATII). Depolymerization of cellular microtubules by colchicine inhibited the effect of DA on HVT ventilated rats as well as on Na+-K+-ATPase activity in ATII cells. Neither DA nor colchicine affected the short-term Na+-K+-ATPase alpha1- and beta1-subunit mRNA steady-state levels or total alpha1- and beta1-subunit protein abundance in ATII cells. Thus we reason that DA improved alveolar fluid reabsorption in rats ventilated with HVT by upregulating the Na+-K+-ATPase function in alveolar epithelial cells.
Asunto(s)
Cardiotónicos/farmacología , Dopamina/farmacología , Agua Pulmonar Extravascular/metabolismo , Alveolos Pulmonares/metabolismo , Respiración Artificial , Animales , Permeabilidad de la Membrana Celular/efectos de los fármacos , Permeabilidad de la Membrana Celular/fisiología , Activación Enzimática/efectos de los fármacos , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Masculino , Alveolos Pulmonares/citología , Alveolos Pulmonares/efectos de los fármacos , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Mucosa Respiratoria/citología , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/genética , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Organismos Libres de Patógenos Específicos , Volumen de Ventilación PulmonarRESUMEN
Dopamine (DA) increases lung edema clearance by regulating vectorial Na+ transport and Na-K-ATPase in the pulmonary epithelium. We studied the role of the mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase (ERK) pathway in the DA regulation of Na-K-ATPase in alveolar epithelial cells (AEC). Incubation of AEC with DA resulted in a rapid stimulation of ERK activity via dopaminergic type 2 receptors. Analysis of total RNA and protein showed a 1.5-fold increase in the Na-K-ATPase beta1-subunit mRNA levels and up to a fivefold increase in beta1-subunit protein abundance after DA stimulation, which was blocked by the MAPK kinase (MEK) inhibitors PD-98059 and U-0126. Also, the DA-ERK pathway stimulated the synthesis of a green fluorescent protein reporter gene driven by the beta1-subunit promoter, which indicates that DA regulates the Na-K-ATPase beta1-subunit at the transcriptional level. The DA-mediated increase in beta1-subunit mRNA protein resulted in an increase in functional Na pumps in the basolateral membranes of alveolar type II cells. These results suggest that the MAPK-ERK pathway is an important mechanism in the regulation of Na-K-ATPase by DA in the alveolar epithelium.
Asunto(s)
Dopamina/fisiología , Proteínas Quinasas Activadas por Mitógenos/fisiología , Alveolos Pulmonares/enzimología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Animales , Células Cultivadas , Dopamina/farmacología , Activación Enzimática , Células Epiteliales/efectos de los fármacos , Células Epiteliales/enzimología , Membranas Intracelulares/metabolismo , Isoenzimas/genética , Masculino , Alveolos Pulmonares/citología , Alveolos Pulmonares/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores de Dopamina D2/fisiología , ATPasa Intercambiadora de Sodio-Potasio/genética , Transcripción Genética/efectos de los fármacos , Transcripción Genética/fisiologíaRESUMEN
We studied whether the beta-adrenergic agonist, isoproterenol (ISO), regulates Na,K-ATPase in alveolar epithelial cells (AEC) via a mitogen-activated protein kinase (MAPK)/extracellular signaling related kinase (ERK) dependent pathway. ISO increased ERK activity in AEC by 10 min via a beta-adrenergic receptor, protein kinase A (PKA)-dependent mechanism. Activation of the MAPK pathway by ISO, resulted in increased Na,K-ATPase beta1 and alpha1 subunit protein abundance in whole cell lysates, which resulted in functional Na, K-ATPases at the basolateral membranes. ISO did not change the alpha1 or beta1 mRNA steady state levels, but rapamycin, the inhibitor of the mammalian target of rapamycin, also blocked the ISO-mediated increase in Na,K-ATPase total protein abundance, suggesting a posttranscriptional regulation. We conclude that ISO, regulates the Na,K-ATPase in AEC via PKA, ERK and rapamycin-sensitive mechanisms.
Asunto(s)
Isoproterenol/farmacología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Sirolimus/farmacología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Agonistas Adrenérgicos beta/farmacología , Animales , Membrana Celular/metabolismo , Células Cultivadas , Colforsina/farmacología , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Inhibidores Enzimáticos/farmacología , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/enzimología , Masculino , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Propranolol/farmacología , Alveolos Pulmonares/citología , Alveolos Pulmonares/efectos de los fármacos , Alveolos Pulmonares/enzimología , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , ATPasa Intercambiadora de Sodio-Potasio/genéticaRESUMEN
The effect of hydrocortisone on platelet activating factor (PAF)-induced pulmonary edema is studied. Thirty four isolated and perfused rabbit lung preparations were used: eight control preparations, eight PAF preparations with two doses of PAF called low dose (LD = 0.5 microg/kg of rabbit weight) and high dose (HD = 1 microg/kg of rabbit weight). Eighteen preparations divided in three groups of six were pretreated with doses of 20, 200 and 2000 mg of hydrocortisone and later given the same doses of PAF as described above. Hydrocortisone significantly decreased (P < 0.05) the effect of PAF LD over the pulmonary arterial pressure (Ppa) in the 200 and 2000 mg groups (58 and 89% decrease, respectively) and it significantly decreased (P < 0.05) the effect of PAF HD over Ppa in all hydrocortisone pretreated groups (48, 70 and 96% decrease, respectively). Fluid filtration rate (FFR) increases mediated by PAF HD were significantly inhibited (P < 0.05) in the 200 and 2000 mg groups (64 and 96% decrease, respectively). We conclude that hydrocortisone inhibits the effect of PAF over the pulmonary circulation.
Asunto(s)
Antiinflamatorios/farmacología , Hidrocortisona/farmacología , Factor de Activación Plaquetaria , Edema Pulmonar/inducido químicamente , Animales , Técnicas In Vitro , Respiración con Presión Positiva , Circulación Pulmonar/efectos de los fármacos , ConejosRESUMEN
Platelet activating factor (PAF) has been implicated in the pathophysiology of acute lung injury. The aim of this work is to study the effect of PAF on isolated and perfused rabbit lungs with blood and with a blood-free solution. 24 isolated and perfused rabbit lungs have been used: 8 control preparations (CP), 4 vehicles preparations (VP), 8 PAF preparations (PP) to which we administered PAF (1 microg/Kg of rabbit weight) and 4 acellular preparations (AP) with the same dose of PAF as in PP but dissolved in BSA-Krebs buffer solution. In the preparations pulmonary artery pressure (Ppa), airway pressure (Paw), left atria pressure (Pla) and fluid filtration rate (FFR) were registered. Ppa resulted in a significant difference in AP vs PP, with a value of 21 cm of water (CI 95%: 12-26) vs 205.1 cm of water (CI 95%: 141.3 - 271) respectively. A increase in FFR was observed in PP but it did not occur in AP, the difference being statistically significant: 5.515 g/min (CI 95 %: 2.425 - 8.865) vs 0.049 g/min (CI 95%: 0.008 - 0.32) respectively. Paw was statistically different in PP vs AP, with a value of 14.3 cm of water (CI 95%: 11.57 - 16.7) vs 8.5 cm of water (CI 95%: 8-9) respectively. These results suggest that PAF does not have a direct effect on the endothelium or smooth muscle in the production of lung edema.
Asunto(s)
Pulmón/irrigación sanguínea , Factor de Activación Plaquetaria/fisiología , Animales , Sangre , Medio de Cultivo Libre de Suero , Técnicas In Vitro , Conejos , Flujo Sanguíneo Regional/fisiologíaRESUMEN
Previous studies have shown that an elevated basal metabolic rate (BMR) is present in elderly malnourished cancer patients. A possible dysfunction of the autonomic nervous system needs to be demonstrated. In aged weight-losing cancer patients (n = 40), aged non-weight-losing cancer patients (n = 30), and aged weight-losing noncancer patients (n = 18), the baseline BMR and heart rate variability were studied. Aged weight-losing cancer patients (n = 40) underwent bioimpedance analysis, ambulatory electrocardiographic monitoring with analysis of heart rate variability, and determination of the BMR. Then, the patients received infusion of Intralipid (Pharmacia, Uppsala, Sweden) without and with propranolol (6 days of 40 mg twice daily) administration. At baseline, a simple correlation between the BMR and the low-frequency component (LF) (r = .42, P < .006) and LF to high-frequency (HF) ratio (r = .51, P < .001) was found. After propranolol administration, the percent decline in the BMR was significantly correlated with the percent decline in the LF (r = .39, P < .01) and LF/HF ratio (r = .53, P < .001). The percent decline in the BMR was not correlated with the HF (r = .13, P < .34) or the plasma noradrenaline concentration (r = .21, P < .20) at any time. With regard to the BMR and substrate oxidation, 6-day propranolol administration plus Intralipid infusion produced the strongest decline in the BMR. This study demonstrates that autonomic nervous system dysfunction occurs and is responsible for the elevated BMR in elderly cancer patients, propranolol administration rectifies the autonomic dysfunction, and Intralipid infusion combined with propranolol administration is useful for enhancing the daily caloric intake without a strong increase in energy expenditure.
Asunto(s)
Antagonistas Adrenérgicos beta/farmacología , Caquexia/tratamiento farmacológico , Caquexia/metabolismo , Emulsiones Grasas Intravenosas/farmacología , Neoplasias/metabolismo , Propranolol/farmacología , Antagonistas Adrenérgicos beta/administración & dosificación , Antagonistas Adrenérgicos beta/uso terapéutico , Anciano , Metabolismo Basal/efectos de los fármacos , Caquexia/etiología , Caquexia/fisiopatología , Calorimetría Indirecta , Catecolaminas/sangre , Impedancia Eléctrica , Emulsiones Grasas Intravenosas/administración & dosificación , Emulsiones Grasas Intravenosas/uso terapéutico , Femenino , Hemodinámica/efectos de los fármacos , Humanos , Pruebas de Función Hepática , Masculino , Neoplasias/complicaciones , Neoplasias/fisiopatología , Propranolol/administración & dosificación , Propranolol/uso terapéutico , Pérdida de Peso/efectos de los fármacosRESUMEN
It is well known that scorpion venom induces lung lesions and respiratory distress which are usually classified as pulmonary oedema (PO). Tityus discrepans is a scorpion that lives in the north-central area of Venezuela, is the most common source of human envenomation here and produces PO. We studied the action of the venom of Tityus discrepans on whole rabbits and on their isolated lungs perfused with Krebs saline with 1 g/l of bovine serum albumin (Krebs-BSA saline). Two milligram of venom were diluted in 250 ml of solution (approximately the rabbit's total blood volume) and used to perfuse isolated lungs. Lung oedema occurred in rabbits which received 1 mg/kg of scorpion venom i.p., heparin prevented the production of this lung oedema. T. discrepans venom produced PO, in rabbits pretreated with 15 mg/kg of ajoene. Yet, Tityus venom had no effects on isolated lungs perfused with citrated or heparinized blood, and in lungs perfused with Krebs-BSA with normal Ca2+. These result show that Tityus venom does not act directly on lungs. Otherwise, we have observed that abundant microthrombi occurred in all rabbit lungs exposed to venom in vivo, suggesting that these clotting alterations are fundamental to produce PO. The presence of intravascular microthrombi is not characteristic of the usual PO hinting that scorpion venom induced pulmonary alterations are a different clinical entity. We thus propose that the use of the term pulmonary oedema in scorpionism should abandoned in favor of scorpion venom respiratory distress syndrome.
Asunto(s)
Síndrome de Dificultad Respiratoria del Recién Nacido/inducido químicamente , Venenos de Escorpión/toxicidad , Presión del Aire , Animales , Presión Sanguínea , Líquido del Lavado Bronquioalveolar , Humanos , Técnicas In Vitro , Recién Nacido , Pulmón/patología , Pulmón/fisiopatología , Masculino , Arteria Pulmonar/fisiología , Edema Pulmonar/inducido químicamente , Edema Pulmonar/patología , Edema Pulmonar/fisiopatología , Conejos , Síndrome de Dificultad Respiratoria del Recién Nacido/patología , Síndrome de Dificultad Respiratoria del Recién Nacido/fisiopatologíaRESUMEN
We have studied the effects of fenoterol on PAF-induced response in pulmonary circulation. We used 28 isolated and perfused rabbit lungs preparations: eight control preparations (CP), four vehicles preparations (VP), eight PAF preparations (PP) with two doses of PAF, one called low dose (LD = 0.5 microg/kg of weight) and the other high dose (HD = 1 microg/kg of weight) and eight Fenoterol preparations (FP) which we administered 0.05 mg of Fenoterol for 15 min, followed by a LD and HD of PAF. FP prevented elevation of pulmonary artery pressure (Ppa) as compared to PP, at LD of PAF: 12.615 (CI 95%: 8.57-20.885) versus 83.705 (CI 95%: 50.55-114.3) cm of water; and at HD of PAF: 19.38 (CI 95%: 11.235-28.94) versus 205.1 (CI 95%: 141.3-271) cm of water respectively. FP prevented the increase in fluid filtration rate (FFR) observed in PP at both doses of PAF LD: 0.765 (CI 95%: 0.07-3.385) versus 0.01 (CI 95%: -0.05-0.005) g/min; HD: 5.515 (CI 95%: 2.425-8.865) versus 0.03 (CI 95%: 0-0.33) g/min. Our results suggest that PAF has a vasoconstrictor effect that produces lung edema and this effect is inhibited by fenoterol.
Asunto(s)
Agonistas Adrenérgicos beta/farmacología , Fenoterol/farmacología , Factor de Activación Plaquetaria , Edema Pulmonar/inducido químicamente , Edema Pulmonar/fisiopatología , Animales , Técnicas In Vitro , Perfusión , Circulación Pulmonar/efectos de los fármacos , ConejosRESUMEN
To assess the responsiveness of cerebral blood flow to arterial carbon dioxide tension (Pa,CO2), arterial oxygen tension (Pa,O2), and pH modifications, in chronic hypercapnia, we measured middle cerebral blood flow velocity (CBFV) by transcranial Doppler ultrasound in 13 chronically hypercapnic, long-term ventilated patients with chronic obstructive pulmonary disease (COPD), in the following conditions: 1) breathing room air; 2) with oxygen supplementation; 3) during mechanical noninvasive intermittent positive pressure ventilation (nIPPV) with O2 enrichment. Under baseline conditions (room air), the CBFV was within the normal range. During oxygen administration, a statistically significant increase was obtained in Pa,O2 (6.5 +/- 0.6 vs 11.2 +/- 1.9 kPa (49.1 +/- 4.3 vs 84.3 +/- 14.6 mmHg)), without relevant variations in: CBFV (54.2 +/- 9.1 cm.s-1), Pa,CO2 (8.6 +/- 1.0 kPa (64.7 +/- 7.7 mmHg)) and hydrogen ion concentration [H+] (42.9 +/- 2.9 nM), compared to baseline values (CBFV = 52.8 +/- 10.7 cm.s-1; Pa,CO2 = (8.4 +/- 0.9 kPa (63.1 +/- 7.1 mmHg; [H+] = 41.8 +/- 2.8 nM). After nIPPV, Pa,O2 did not increase any further (10.6 +/- 1.7 kPa (79.2 +/- 12.7 mmHg)), while CBFV (40.9 +/- 12.6 cm.s-1), Pa,CO2 (7.5 +/- 1.3 kPa (56.2 +/- 9.4 mmHg)) and [H+] (39.1 +/- 4.6 nM) showed a significant reduction compared to oxygen therapy (p < 0.01). We therefore conclude that in chronically hypercapnic long-term ventilated patients cerebral blood flow depends mainly on changes in Pa,CO2 and [H+], whilst oxygen does not seem to interfere with cerebral flow velocity. The reduction of Pa,CO2, due to mechanical ventilation, may determine cerebral blood vessel constriction, with possible impairment of cerebral functions.
Asunto(s)
Circulación Cerebrovascular/fisiología , Hipercapnia/fisiopatología , Hipoxia/fisiopatología , Enfermedades Pulmonares Obstructivas/fisiopatología , Velocidad del Flujo Sanguíneo/fisiología , Femenino , Humanos , Hipercapnia/terapia , Hipoxia/terapia , Ventilación con Presión Positiva Intermitente , Enfermedades Pulmonares Obstructivas/terapia , Masculino , Persona de Mediana Edad , Terapia por Inhalación de Oxígeno , Ultrasonografía Doppler TranscranealAsunto(s)
Colitis Ulcerosa/diagnóstico , Enfermedades Pulmonares/diagnóstico , Adulto , Anciano , Broncoscopía , Colitis Ulcerosa/complicaciones , Femenino , Humanos , Pulmón/diagnóstico por imagen , Enfermedades Pulmonares/etiología , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos XRESUMEN
Admission and discharge criteria are important decision-making components. Nursing care and management must be considered an imperative part of this criteria. The Nursing Evaluation of Nursing Intensity could identify those patients that may be passed over under standard admission criteria to Intensive Care Units. This tool augments the transfer process as well as helps to determine patient location.
Asunto(s)
Evaluación en Enfermería , Transferencia de Pacientes , Carga de Trabajo , Cuidados Críticos , HumanosRESUMEN
Thirty chronic, hypoxaemic patients with a mean arterial oxygen tension (PaO2) of 6.81 kPa (SD 0.56) in air were tested using the Travelair. The study was performed at rest, allowing the patients to breathe in the following conditions: a) compressed air; b) continuous oxygen flow from the concentrator; c) oxygen from the concentrator in demand-valve mode (DV) with an activation time (AT) of 375 ms; d) DV with AT of 750 ms; e) DV with AT of 1,125 ms; f) DV with AT 1,500 ms; and g) continuous oxygen from the hospital outlet at 2 l.min-1. The mean (SD) SaO2% values at each consecutive step were: a) 87.2 (5.0)%; b) 93.0 (3.0)%; c) 93.9 (2.8)%; d) 94.2 (2.5)%; e) 94.0 (2.7)%; f) 94.1 (2.7)%; and g) 94.8 (2.4)%, respectively. Each of the results obtained with DV (b-f) was statistically different from those obtained breathing air (a) or oxygen (g). The mean (SD) respiratory rates at each consecutive step were: a) 21.2 (4.1); b) 21.0 (4.0); c) 21.3 (4.0); d) 21.0 (3.6); e) 20.7 (3.4); f) 21.0 (3.8); and g) 21.2 (3.8) breaths.min-1, respectively. No relationship was found between the mean oxygen saturations and the mean respiratory frequencies of the patients in each condition tested. With the concentrator on demand, the average of the best SaO2% obtained by the patients in whatever of the four DV activation time modes (conditions c-f) was 94.8 (2.4)%, and no statistical difference was detected between this result and the SaO2% obtained with 2 l.min-1 of continuous oxygen.
Asunto(s)
Terapia por Inhalación de Oxígeno/instrumentación , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hipoxia/terapia , Masculino , Persona de Mediana EdadRESUMEN
PIP: The recommendations of a staff member of the Paulina Luisi Movement and member of the Women's Global Network for Reproductive Rights were six-fold. Being a woman was considered a risk factor for AIDS. AIDS and HIV infection prevention must concentrate on prevention of sexually transmitted diseases (STDs). 1) Women's organizations have the responsibility for sensitizing health professionals about STDs and AIDS and break the "culture of silence." 2) Women's health focus must actively include prevention of AIDS/HIV. 3) The Pap test must be included routinely as part of public and individual health services and conducted with high quality standards. 4) The flow of communication about women's health issues must be initiated between health professionals and women advocates with the objective of changing concepts and attitudes and of developing complementary strategies. 5) The strategy of promoting condom use and quality information does not address the larger issue of discrimination against women. Gender relations between spouses and between patient and doctor must be based on responsibility, reciprocity, and autonomy. Strategies must aim to combat the negativity in society that prevents responsible gender relations. 6) Professional women who have an awareness of gender issues must be engaged in international and governmental institutions with decision making power. Sex and women's health have been lesser priorities. The health system has responded to women as "objects" rather than subjects of attention. Women's position sexually and socially makes them more vulnerable to AIDS and HIV infections, which may be transmitted through a single sexual contact. STDs increase the risk of AIDS. Latin American women feel shame about STDS, while men respond to STDs as a condition of their sexual virility or potency. Treatment of STDS, much less AIDS prevention, is inadequate. The health system must stop treating women as objects and give them their right to health.^ieng
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida , Directrices para la Planificación en Salud , Derechos Humanos , Medicina Reproductiva , Américas , Países en Desarrollo , Enfermedad , Infecciones por VIH , Salud , América Latina , América del Sur , Uruguay , VirosisRESUMEN
Continuous oxygen therapy is essential in the treatment of advanced chronic obstructive pulmonary disease (COPD). A transtracheal oxygen administration system is more effective in the rehabilitation of these patients than are traditional systems, nasal canula or Venturi mask devices. In the present work the authors describe a simple technique for introducing the transtracheal catheter. The procedure is performed under local anesthesia and a Teflon catheter is inserted between the second and third tracheal rings. In a case study of 12 patients the complications encountered included purulent drainage of the skin tract and accidental displacement of the transtracheal catheter. No procedure related deaths were incurred. Subjectively, the patients experience a sensation of being able to breathe more easily, thus resulting in increased outdoor activity.